US healthcare executives call for a single federal AI policy framework to streamline adoption and overcome regulatory obstacles, citing specific imaging AI use cases.
Key Details
- 1Healthcare Leadership Council surveyed 27 member organizations, spanning providers, insurers, pharma, and tech.
- 2Executives warn that varying state-level rules hinder AI progress and patient care improvement.
- 3Cited barriers: inconsistent regulations, data access challenges, capability and trust gaps.
- 4Recommendations include centralized federal legislation, standardizing data and interoperability, and workforce AI upskilling.
- 5Report highlights radiology as a key AI use case, stressing the need for diverse and representative training data.
- 6Executive order from the White House has sought to address state regulatory fragmentation.
Why It Matters
Standardized, nationwide AI policy would reduce complexity and accelerate adoption of AI—including imaging AI—across healthcare settings. This would help radiology departments more confidently deploy AI solutions, improving patient outcomes and operational efficiency.
Source
Radiology Business
Related News
•AuntMinnie
Vast Majority of FDA-Cleared Radiology AI Devices Lack Outcome Trials
Only 0.3% of FDA-cleared radiology AI devices have registered trials on patient outcomes, raising concerns about evidence standards.
•Radiology Business
Radiology Partners Urges FDA for Clarity on Imaging AI Regulations
Radiology Partners and Mosaic Clinical Technologies petition the FDA for clearer regulatory guidelines on imaging AI vision-language models.
•Radiology Business
FDA Solicits Public Input on Regulating Generative AI in Medical Devices
The FDA is seeking public feedback on how to regulate generative AI in medical devices, recognizing both its promise and risks.